Immediate Impact
4 from Science/Nature 60 standout
Citing Papers
Bimekizumab versus Secukinumab in Plaque Psoriasis
2021 Standout
Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs
2021 Standout
Works of Elaine E. L. Wang being referenced
Anti–IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Elaine E. L. Wang | 1570 | 1034 | 519 | 44 | 2.4k | |
| Jan Bonhoeffer | 1188 | 446 | 392 | 76 | 2.8k | |
| Marjo Renko | 1197 | 799 | 326 | 138 | 2.7k | |
| Robert Pickard | 971 | 915 | 897 | 95 | 3.3k | |
| Stanley A. Gall | 1170 | 290 | 571 | 130 | 3.0k | |
| Lynn B. Duffy | 1928 | 579 | 309 | 72 | 3.0k | |
| René F. Kornelisse | 782 | 480 | 184 | 65 | 1.9k | |
| François Angoulvant | 901 | 510 | 795 | 84 | 2.5k | |
| Jörn-Hendrik Weitkamp | 904 | 919 | 576 | 87 | 3.2k | |
| Mohan Pammi | 831 | 1071 | 442 | 93 | 3.2k | |
| Thomas Bregenzer | 1183 | 291 | 564 | 51 | 2.9k |
All Works
Loading papers...